ZOLL Launches the First Pediatric Electrodes That Report CPR Quality
CHELMSFORD, Mass.--(BUSINESS WIRE)--Dec 12, 2012--ZOLL ® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its new FDA-cleared OneStep™ Pediatric CPR Electrodes are the only electrodes on the market with a built-in sensor that reports CPR quality on young children up to 8 years of age. This first-of-its-kind electrode provides optimal support for pediatric resuscitation when paired with the ZOLL R Series ® Monitor/Defibrillator and its CPR Dashboard ™.
The R Series offers the most extensive pediatric capabilities available in a professional defibrillator with smart, simple, and safe pediatric support. The OneStep CPR Pediatric Electrodes can be used for monitoring, pacing, and defibrillation, as well as CPR.
“Too often, clinicians who treat children need to compromise and adapt devices designed for adults because there isn’t a pediatric version available,” said Jonathan Rennert, President of ZOLL. “We recognize that the needs of children are different from adults and have provided a range of capabilities to support the special needs of the youngest patients.” With the vast majority of pediatric arrests due to respiratory failure, the importance of high-quality CPR cannot be minimized. The 2010 American Heart Association Guidelines place a heavy emphasis on good-quality CPR. Without a built-in CPR sensor, it’s difficult to judge how hard clinicians are pushing when performing CPR on a child. The FDA-cleared CPR Dashboard for the R Series reports the actual depth and rate of compressions delivered. A CPR timer gauges the CPR periods for optimal ventilation, while a metronome is activated if the rate falls below 100 compressions per minute. CPR data can be reviewed after the code and used for quality improvements.
In addition, ZOLL’s See-Thru CPR ®, a proprietary filter that allows clinicians to see if an organized rhythm is developing during CPR, is also active with the pediatric CPR pads. See-Thru CPR helps to reduce the duration of interruptions to CPR and speeds time to shock when indicated.
In the event of a cardiac arrest, as soon as the pediatric electrodes are placed on the patient, the R Series immediately adjusts its AED analysis algorithm to pediatric parameters in order to reduce the likelihood that a compensating rhythm will be terminated. This ensures that any unique pediatric ECG morphology will be accurately identified when a shock is indicated.
The R Series is designed with a focus on simplicity to minimize errors and confusion. When the pediatric electrodes are attached to the R Series, the shock energy is automatically lowered to a starting dose of 50 joules. The R Series then measures the actual patient impedance and adjusts accordingly, delivering sufficient current for effective conversion while not delivering inaccurate energy to the child. The R Series can be configured to automatically lower the setting to whatever dose is desired, even as low as one joule.
About ZOLL Medical Corporation ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2012 ZOLL Medical Corporation. All rights reserved. CPR Dashboard, OneStep, R Series, See-Thru CPR, and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.CONTACT: ZOLL Medical Corporation Diane Egan, +1-978-421-9637 email@example.com KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS INDUSTRY KEYWORD: TECHNOLOGY HARDWARE SOFTWARE HEALTH CARDIOLOGY MEDICAL DEVICES FDA SOURCE: ZOLL Medical Corporation Copyright Business Wire 2012 PUB: 12/12/2012 11:36 AM/DISC: 12/12/2012 11:36 AM http://www.businesswire.com/news/home/20121212006160/